Неврология, нейропсихиатрия, психосоматика (Sep 2011)
Poststroke cognitive impairments and their therapy with ceraxon
Abstract
Objective: to evaluate the effect of citicoline (ceraxon) on recovery of cognitive functions in patients after ischemic stroke. Subjects and methods. Thirty-three patients (13 males and 20 women) aged 46-82 years (mean age 66.5±6.75 years) after ischemic stroke were examined 3 months to 1 year after its development. Neuropsychological examination showed that all the patients had mild or moderate cognitive impairments as disorders of memory, attention, and thinking. Results and discussion. Ten-day treatment with citicoline (ceraxon) in a dose of 500 or 1000 mg/day caused positive changes in the neurody-namic characteristics of cognitive functions, and improvements in memory, thinking, and health in the patients. Cognitive improvement was more significant when ceraxon was used in a dose of 1000 mg/day.
Keywords